Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 17, 2022

Primary Completion Date

April 9, 2025

Study Completion Date

April 9, 2025

Conditions
Hepatic Impairment
Interventions
DRUG

Rupatadine

10mg tablets

Trial Locations (7)

28006

Hospital Universitario De La Princesa, Madrid

28040

Hospital Clinico San Carlos, Madrid

28046

Hospital Universitario La Paz, Madrid

4250-449

BlueClinical Phase I, Porto

4434-502

Centro Hospitalar De Vila Nova De Gaia Espinho, Gaia

4450-113

Hospital Pedro Hispano, Matosinhos Municipality

08003

Municipal Institute Of Medical Investigation, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Noucor Health S.A.

INDUSTRY